Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in China / NCT05804851
Active, not recruiting Observational

Skin Microbiome of Chinese Population Cohort Study

NCT05804851 · tracked via the Priya Life Science China tracker
Sponsor
Westlake University
Phase
Observational
Started
2023-05-08
Last updated
2026-09-29

Condition(s) studied

Skin Microbiome

Study summary

This observational study aims to investigate the relationship between public health and the skin microbiome in the province of Zhejiang. Due to the lack of current research on the skin microbiome, the following general questions will be investigated in this study: 1) What connection exists between dietary practices and facial skin microbiome? 2) How do people's lifestyle routines affect the facial skin microbiome? 3) What effects does the altered living environment have on people's facial skin microbiomes? 4) How do the seasons affect people's facial skin microbiomes?

Every 3 to 4 months, the participants' facial skin microbiota samples will be taken, and they will be asked to complete a survey.

Eligibility

Sex
ALL
Min age
10 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * ages from 10+. Exclusion Criteria: * a severe medical history, including a history of surgery or medication, or serious illnesses such as cancer, liver disease, kidney disease, or craniocerebral trauma. * recent medical treatment (topical antibiotics, corticosteroids, and other anti-inflammatory drugs within 4 weeks, and systemic antibiotics, corticosteroids, and other immunosuppressive drugs within 6 months)

Primary outcome measure(s)

  • Changes in facial microbiota profiling — Day 1, Day 90, Day 180, Day 270, and Day 360
    Quantitative and qualitative analysis of bacteria population from the sample, rRNA and metagenome sequencing will be conducted on each sample

Trial sites (1)

FacilityCityRegionStatus
Westlake University Hangzhou Zhejiang

More Westlake University trials in China

Study of Clostridioides Difficile in Infants Recruiting
Westlake Longevity Cohort Recruiting
Westlake Frequent-sampling Cohort 2 Active, not recruiting
Westlake Precision Birth Cohort Active, not recruiting
Dynamic Monitoring of Urinary Electrolytes Active, not recruiting

Other trials for the same condition

The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer Patients Recruiting
Modulating the Skin Microbiome to Prevent Radiation Dermatitis in Breast Cancer Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05804851 on ClinicalTrials.gov ↗ ← All trials in China